David Virós Porcuna Head of Department of Otolaryngology Head and Neck Surgery. Institutions of which they are part Head of group Head and Neck Cancer: Biomedical Research Cancer Stem cells Vall Hebron Institut de Recerca Ear, Nose and Throat General Hospital LinkedIn Twitter Orcid Email David Virós Porcuna LinkedIn Twitter Orcid Email Institutions of which they are part Head of group Head and Neck Cancer: Biomedical Research Cancer Stem cells Vall Hebron Institut de Recerca Ear, Nose and Throat General Hospital Head of Department of Otolaryngology Head and Neck Surgery.
I am a doctor specializing in Otorhinolaryngology. I have more than 15 years of experience after completing the training period at the Hospital de la Santa Cruz y San Pablo in 2009. Subsequently, I focused my activity on head and neck oncology. I obtained a scholarship for training, followed by observership in the Netherlands and completing a master's degree in reconstructive microsurgery. From 2010 to 2014 I worked at the Sant Joan Despí “Moisès Broggi” Hospital, in 2015 at the Vall d'Hebron Hospital and between 2016 and 2024 at the Germans Trias i Pujol University Hospital. Since 2017 I have promoted the development of robotic surgery in our specialty until obtaining a pioneering program of national and international prestige. I obtained a Doctor of Surgery degree from the Autonomous University of Barcelona with an Excellent Cum Laude qualification in February 2010. Subsequently, I have been involved in multiple research projects, as well as in teaching as an associate professor at the Autonomous University of Barcelona. I have also directed multiple courses focused on minimally invasive head and neck surgery. I am the author or co-author of numerous articles published in national and international journals. I have collaborated in multiple national and international scientific societies.
Projects II Congreso Internacional de cáncer de cabeza y cuello IP: Matilde Lleonart Pajarin Collaborators: David Virós Porcuna Funding agency: Ajuntament Barcelona Funding: 2980 Reference: 102034195-25 Duration: 01/09/2025 - 30/06/2026 Overcomming chemoresistance in HNSCC IP: Matilde Lleonart Pajarin Collaborators: Katerin Ingrid Rojas Laimito, Yoelsis Garcia Mayea, David Virós Porcuna, Josep Castellví Vives, María Garrido Martínez, Pablo Verges Fort, Marina Bataller Fernández Funding agency: Fundación hna Funding: 50000 Reference: FUND.HNA/PREMI/LLEONART/2025 Duration: 01/10/2025 - 30/09/2027 Nanocápsulas que combinan nuevos fármacos con quimioterapia convencional para curar cánceres resistentes IP: Matilde Lleonart Pajarin Collaborators: Katerin Ingrid Rojas Laimito, Irene Braña Garcia, Yoelsis Garcia Mayea, David Virós Porcuna, Juan Fernando Fuentes Cabrera, Josep Castellví Vives, Marina Bataller Fernández Funding agency: Instituto de Salud Carlos III Funding: 318750 Reference: AC24/00057 Duration: 01/01/2025 - 31/12/2027
